Webinar: DISCO-MS Extension Data and Other Key Updates in MS Research

Join us for a special webinar with neurologist Dr. John Corboy as he shares the latest research updates in multiple sclerosis (MS), with a spotlight on data from the DISCO-MS extension trial. This important study examines the impact of discontinuing disease-modifying therapies (DMTs) in older adults with stable MS—offering meaningful insights for patients, caregivers, support partners, and healthcare providers. Dr. Corboy will walk through the key findings from the extension phase of the DISCO-MS trial and discuss how they may influence treatment decisions and long-term MS care. He’ll also share highlights from other recent studies that could help shape the future of MS treatment and management.

Ask questions ahead of time at the prompt after you register, or by emailing us at education@mscenter.org.

All registrants will receive an email after the event with a link to a video recording of the Webinar.

Join us on Z oom!

Please watch your email or check back here for the Zoom link as the event date approaches.

ABOUT THE PRESENTER

Dr. John Corboy is the former Medical Director of the Rocky Mountain MS Center, retiring from daily duties in 2024. He is a graduate of University of Pennsylvania, and did his neurology residency there, with a fellowship at Johns Hopkins University in Baltimore. He specialized in MS and neurovirology at the University of Minnesota Medical Center before coming to Colorado in 1994. In 1997, he founded the University of Colorado Multiple Sclerosis Center, now transformed into the Rocky Mountain Multiple Sclerosis Center at University of Colorado (RMMSC at CU), a multidisciplinary group offering state-of-the-art care and research to multiple sclerosis patients. Dr. Corboy is the founding editor of Neurology: Clinical Practice, the clinical journal of the American Academy of Neurology, retired Director of the RMMSC at CU, and retired Medical Director of the Rocky Mountain MS Center.

Thanks to Our Supporters

MS Center Webinars are made possible in part by patient education grants and/or sponsorships from Bristol Myers Squibb, EMD Serono, and Novartis.